NCT06375239View on ClinicalTrials.gov

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

RecruitingOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

April 5, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Retinitis PigmentosaChoroideremiaStargardt Macular DystrophyStargardt DiseaseGeographic Atrophy from Age-related Macular DegenerationX-lined RetinoschisisRetinal Dystrophies

Trial Locations (1)

92612

RECRUITING

Vision Research and Assessment Institute, Irvine

All Listed Sponsors

collaborator

The Vision Research and Assessment Institute (VRAI)

UNKNOWN

lead

Ray Therapeutics, Inc.

INDUSTRY